The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 |
|---|---|
| Net loss | -17,740 |
| Depreciation and amortization | 56 |
| Share-based compensation | 407 |
| Change in fair value of convertible notes payable | -728 |
| Change in fair value of warrant liabilities | 16 |
| Amortization of debt discount and debt issuance costs | 127 |
| Accounts receivable | 419 |
| Inventory | 593 |
| Other assets | 139 |
| Accounts payable | 727 |
| Accrued liabilities and other | -898 |
| Net cash used in operating activities | -17,728 |
| Purchases of property and equipment | 42 |
| Net cash used in investing activities | -42 |
| Exercise of common stock options | 358 |
| Proceeds from issuance of convertible notes payable | 14,102 |
| Proceeds from the related party issuance of convertible notes payable | 25,898 |
| Proceeds from issuance of series f redeemable convertible preferred stock, net of issuance costs | 0 |
| Proceeds from the related party issuance of series f redeemable convertible preferred stock, net of issuance costs | 0 |
| Payment of deferred offering costs | 450 |
| Net cash provided by financing activities | 39,908 |
| Net change in cash and cash equivalents | 22,138 |
| Cash and cash equivalents, beginning of period | 33,587 |
| Cash and cash equivalents, end of period | 55,725 |
Mobia Medical, Inc. (MOBI)
Mobia Medical, Inc. (MOBI)